Literature DB >> 29719349

The Application of Cognitive Remediation Therapy in The Treatment of Mental Disorders.

Qing Fan1, Liwei Liao1, Guihua Pan1.   

Abstract

Cognitive impairment is common in patients with mental disorders. At present, one of the only effective ways to improve cognitive impairment is cognitive remediation therapy. This article reviews the application of cognitive remediation therapy in the treatment of mental disorders.

Entities:  

Keywords:  cognitive remediation therapy; mechanism of action; mental disorders

Year:  2017        PMID: 29719349      PMCID: PMC5925589          DOI: 10.11919/j.issn.1002-0829.217079

Source DB:  PubMed          Journal:  Shanghai Arch Psychiatry        ISSN: 1002-0829


Cognitive function refers to a series of related conscious/unconscious mental activities, including pre-attentive sensory gating, attention, learning and memory, problem solving, planning, reasoning and judgment, understanding and representation, creativity, intuition and insight, spontaneous thoughts, introspection, self-consciousness and meta-cognition.[ It is now recognized that a variety of common mental disorders, such as anxiety spectrum disorders, mood disorders, schizophrenia and others, are accompanied by defects in cognitive function, such as in, attention, working memory, executive function, procedural memory and learning, processing speed, fear-inhibitory learning (Fear extinction), semantic memory defects etc.[ Cognitive remediation therapy is the only effective way to improve cognitive impairment in patients with mental disorders.

1. Cognitive Remediation Therapy

Cognitive Remediation Therapy (CRT) is a method based on behavior training in order to sustainably and widely improve cognitive activities (attention, memory, executive function and so on).[ In recent years, with the development of computer technology, the Computerized Remediation Therapy (CCRT) has been derived from CRT. CCRT is a way to improve cognitive function by training individual brain specific brain circuits, which is based on the neural plasticity of the individual. Compared with CRT, CCRT can be more standardized, affordable, noninvasive, and the treatment makes possible real-time adjustment of treatment difficulty and accurate recording of the training results down to the millisecond. Thus is it possible to maximize efficacy, reduce human error and improve cost benefit.[

2. Cognitive Remediation Therapy in the Treatment of Mental Disorders

2.1 Schizophrenia

In 2011, a meta-analysis of 40 randomized controlled trials (RCT) showed[ that CRT had a low-moderate efficacy and a certain degree of continuity for the improvement of schizophrenia in patients with overall cognition (Effect Size, ES)=0.45) and function (ES=0.42) and also has a low curative effect on mental symptoms, but this effect disappeared at follow-up. CRT combined with other rehabilitation therapy can improve the functional outcome of patients with schizophrenia more effectively. Treatment parameter settings (such as cognitive modification treatment, course of treatment and computer use) were not associated with cognitive outcome measures. CRT is more effective for stationary phase patients. In 2015, another meta-analysis with inclusion of 11 RCTs showed that [ CRT has no significant effect on the overall cognitive function in first-episode schizophrenia, but it has a low curative effect on the single cognitive function dimension of visual learning and memory (ES=0.23). This paper showed that CRT has low efficacy in improving psychiatric symptoms (ES=0.19) and social functioning (ES=0.18) in first-episode schizophrenia.

2.2 Other Mental Disorders

In addition, in recent years multiple Meta-analyses have shown that cognitive remediation therapy has a low to high degree of efficacy in improving anxiety disorder, depression, eating disorders, schizoaffective disorder, mild cognitive impairment /Cognitive function, psychiatric symptoms, and the daily functioning of patients with early stage dementia.[ In short, cognitive deficits are not only state characteristics but also trait characteristics in many mental disorders. In the case of schizophrenia, cognitive impairment is the core symptom independent of both positive and negative symptoms. At present, antipsychotic drugs which are the major treatment for mental disorders have little effect on cognitive deficits in schizophrenia.[ In contrast, CRT has a definite ameliorative effect on cognitive and psychiatric symptoms in a variety of patients with common mental disorders. Therefore, the treatment guidelines of United States / Canada / the United Kingdom and other countries recommend cognitive remediation therapy as a treatment for stable and refractory schizophrenia.[ In general, CRT content includes repetitive exercises, strategies for how to make up for cognitive defects, and how to extend training tasks to everyday learning and work.[ Compared with other behavioral therapies for schizophrenia, the advantage of CRT is that it can simultaneously correct the patient’s cognitive defects and behavioral symptoms.[ The ultimate goal of CRT is to improve the patient’s social adaptation by improving certain cognitive dimensions. However, after testing the current CRT regiment, the association between schizophrenia specific cognitive function improvement and social adaptation was still low.[ In addition the consistency on (still taking schizophrenia as an example) the first, second, fourth, fifth and eleventh items of the A Measurement Tool to Assess Systematic Reviews (AMSTARZ) is less than 50% when meta-analyses were conducted for CRT. Furthermore, the data extraction, gray literature retrieval, literature quality evaluation were below the standards recommended by AMSTAR.[ The major limitations of CRT in psychiatric disorders include its failure to illuminate underlying mechanisms for patients’ issues, lack of standardization in treatment settings, lack of clarity on what CRT’s actual curative effects are, and CRT’s curative effects not being closely associated with patient social adaptation. For example, the factors that currently affect the efficacy of CRT might include individual characteristics (such as age, genotype and brain development status and so on), treatment characteristics (such as method, frequency and process etc.) and improving cognitive instruments (such as exercise, nootropic drugs and physical therapy etc.) [. Cognitive impairment in different mental disorders is not the same, lacking of corresponding set of evaluation tools also limits the relevant efficacy of study. Therefore, there is still a need for further development and establishment of more targeted and standardized cognitive remediation therapies, a need for more large sample RCTs of CRT to patients with mental disorders, and a need to carry out further research for factors influencing CRT efficacy. Further meta-analyses of CRT should adhere most closely to the standards set forth in AMSTAR. Finally, the development of targeted, standardized social adaptation skills for the CRT exercises is also essential to improvement of the cognitive function and social adaptability of patients with mental disorders.
  17 in total

Review 1.  A systematic review and meta-analysis of cognitive remediation in early schizophrenia.

Authors:  Emily R Revell; Jo C Neill; Michael Harte; Zarshed Khan; Richard J Drake
Journal:  Schizophr Res       Date:  2015-08-21       Impact factor: 4.939

Review 2.  Cognitive remediation in schizophrenia: A methodological appraisal of systematic reviews and meta-analyses.

Authors:  Shayden Bryce; Elise Sloan; Stuart Lee; Jennie Ponsford; Susan Rossell
Journal:  J Psychiatr Res       Date:  2016-01-05       Impact factor: 4.791

3.  The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity.

Authors:  Keith H Nuechterlein; Michael F Green; Robert S Kern; Lyle E Baade; Deanna M Barch; Jonathan D Cohen; Susan Essock; Wayne S Fenton; Frederick J Frese; James M Gold; Terry Goldberg; Robert K Heaton; Richard S E Keefe; Helena Kraemer; Raquelle Mesholam-Gately; Larry J Seidman; Ellen Stover; Daniel R Weinberger; Alexander S Young; Steven Zalcman; Stephen R Marder
Journal:  Am J Psychiatry       Date:  2008-01-02       Impact factor: 18.112

4.  Mental health system funding of cognitive enhancement interventions for schizophrenia: summary and update of the New York Office of Mental Health expert panel and stakeholder meeting.

Authors:  Susan R McGurk; Kim T Mueser; Nancy H Covell; Keith D Cicerone; Robert E Drake; Steven M Silverstein; Alice Medialia; Robert Myers; Alan S Bellack; Morris D Bell; Susan M Essock
Journal:  Psychiatr Rehabil J       Date:  2013-09

Review 5.  “Meta-guidelines” for the management of patients with schizophrenia.

Authors:  Stephen M Stahl; Debbi A Morrissette; Leslie Citrome; Stephen R Saklad; Michael A Cummings; Jonathan M Meyer; Jennifer A O'Day; Laura J Dardashti; Katherine D Warburton
Journal:  CNS Spectr       Date:  2013-06       Impact factor: 3.790

Review 6.  Cognitive remediation in anorexia nervosa and related conditions: a systematic review.

Authors:  Kate Tchanturia; Naima Lounes; Sue Holttum
Journal:  Eur Eat Disord Rev       Date:  2014-10-03

Review 7.  Non-pharmacological interventions for adults with mild cognitive impairment and early stage dementia: An updated scoping review.

Authors:  Juleen Rodakowski; Ester Saghafi; Meryl A Butters; Elizabeth R Skidmore
Journal:  Mol Aspects Med       Date:  2015-06-10

8.  A meta-analysis of cognitive remediation for schizophrenia: methodology and effect sizes.

Authors:  Til Wykes; Vyv Huddy; Caroline Cellard; Susan R McGurk; Pál Czobor
Journal:  Am J Psychiatry       Date:  2011-03-15       Impact factor: 18.112

Review 9.  Evidence for Cognitive Remediation Therapy in Young People with Anorexia Nervosa: Systematic Review and Meta-analysis of the Literature.

Authors:  Kate Tchanturia; Lucia Giombini; Jenni Leppanen; Emma Kinnaird
Journal:  Eur Eat Disord Rev       Date:  2017-07

Review 10.  Thinking about the future cognitive remediation therapy--what works and could we do better?

Authors:  Til Wykes; Will D Spaulding
Journal:  Schizophr Bull       Date:  2011-09       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.